Luca Lacitignola

Prof. Luca Lacitignola

Università degli Studi Aldo Moro (Bari)
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Veterinary Medicine International
Verified
Journal Article
Open access
PDF file
ACANTONIO CROVACE
ANTONIO CROVACE
LLLuca Lacitignola
Luca Lacitignola
GRGiacomo Rossi
Giacomo Rossi
EFEdda Francioso
Edda Francioso
The aim of this study was to compare treatment with cultured bone marrow stromal cells (cBMSCs), bone marrow Mononucleated Cells (BMMNCs), and placebo to repair collagenase-induced tendinitis in horses. In six adult Standardbred horses, 4000 IU of collagenase were injected in the superficial digital flexor tendon (SDFT). Three weeks after collagenase treatment, an average of either5.5×106cBMSCs or1.2×108BMMNCs, fibrin glue, and saline solution was injected intralesionally in random order. In cBMSC- and BMMNCS-treated tendons, a high expression of cartilage oligomeric matrix protein (COMP) and type I collagen, but low levels of type III collagen were revealed by immunohistochemistry, with a normal longitudinally oriented fiber pattern. Placebo-treated tendons expressed very low quantities of COMP and type I collagen but large numbers of randomly oriented type III collagen fibers. Both cBMSC and BMMNCS grafts resulted in a qualitatively similar heling improvement of tendon extracellular matrix, in terms of the type I/III collagen ratio, fiber orientation, and COMP expression.

16 July 2007 in Veterinary Research Communications
Verified
Journal Article
Closed access
PDF file
ACANTONIO CROVACE
ANTONIO CROVACE
LLLuca Lacitignola
Luca Lacitignola
RSR. De Siena
R. De Siena
GRG. Rossi
G. Rossi
EFE. Francioso
E. Francioso

1 June 2014 in Critical Care Medicine
Verified
Journal Article
Closed access
SGSalvatore Grasso
Salvatore Grasso
TSTania Stripoli
Tania Stripoli
PMPalma Mazzone
Palma Mazzone
MPMarco Pezzuto
Marco Pezzuto
LLLuca Lacitignola
Luca Lacitignola
Francesco  StaffieriFrancesco Staffieri
Francesco Staffieri
The Acute Respiratory Distress Syndrome Network protocol recommends limiting tidal volume and plateau pressure; it also recommends increasing respiratory rate to prevent hypercapnia. We tested a strategy that combines the low tidal volume with lower respiratory rates and minimally invasive CO2 removal. Ten lung-damaged pigs (instilled hydrochloride). Two conditions randomly applied in a crossover fashion: the Acute Respiratory Distress Syndrome Network protocol and the Acute Respiratory Distress Syndrome Network protocol plus lower respiratory rate plus minimally invasive Co2 removal. A similar arterial Co2 partial pressure was targeted in the two conditions. Physiological parameters, computed tomography scans, plasma and bronchoalveolar lavage concentrations of interleukin-1β, interleukin-6, interleukin-8, interleukin-10, interleukin-18, and tumor necrosis factor-α. During the lower respiratory rate condition, respiratory rate was reduced from 30.5 ± 3.8 to 14.2 ± 3.5 (p < 0.01) breaths/min and minute ventilation from 10.4 ± 1.6 to 4.9 ± 1.7 L/min (p < 0.01). The extracorporeal device removed 38.9% ± 6.1% (79.9 ± 18.4 mL/min) of CO2 production. During the lower respiratory rate condition, interleukin-6, interleukin-8, and tumor necrosis factor-α concentrations were significantly lower in plasma; interleukin-6 and tumor necrosis factor-α concentrations were lower in bronchoalveolar lavage, whereas the concentrations of the other cytokines remained unchanged. The strategy of lower respiratory rate plus minimally invasive extracorporeal CO2 removal was feasible and safe and, as compared with the Acute Respiratory Distress Syndrome Network protocol, reduced the concentrations of some, but not all, of the tested cytokines without affecting respiratory mechanics, gas exchange, and hemodynamics.

7 August 2008 in Veterinary Research Communications
Verified
Journal Article
Closed access
PDF file
LLLuca Lacitignola
Luca Lacitignola
ACANTONIO CROVACE
ANTONIO CROVACE
GRG. Rossi
G. Rossi
EFE. Francioso
E. Francioso

Verified
Journal Article
Open access
PDF file
GCGiuseppe Castellano
Giuseppe Castellano
ASALESSANDRA STASI
ALESSANDRA STASI
RFRossana Franzin
Rossana Franzin
FSFabio Sallustio
Fabio Sallustio
CDChiara Divella
Chiara Divella
LGLoreto Gesualdo
Loreto Gesualdo
During sepsis, the increased synthesis of circulating lipopolysaccharide (LPS)-binding protein (LBP) activates LPS/TLR4 signaling in renal resident cells, leading to acute kidney injury (AKI). Pericytes are the major source of myofibroblasts during chronic kidney disease (CKD), but their involvement in AKI is poorly understood. Here, we investigate the occurrence of pericyte-to-myofibroblast trans-differentiation (PMT) in sepsis-induced AKI. In a swine model of sepsis-induced AKI, PMT was detected within 9 h from LPS injection, as evaluated by the reduction of physiologic PDGFRβ expression and the dysfunctional α-SMA increase in peritubular pericytes. The therapeutic intervention by citrate-based coupled plasma filtration adsorption (CPFA) significantly reduced LBP, TGF-β, and endothelin-1 (ET-1) serum levels, and furthermore preserved PDGFRβ and decreased α-SMA expression in renal biopsies. In vitro, both LPS and septic sera led to PMT with a significant increase in Collagen I synthesis and α-SMA reorganization in contractile fibers by both SMAD2/3-dependent and -independent TGF-β signaling. Interestingly, the removal of LBP from septic plasma inhibited PMT. Finally, LPS-stimulated pericytes secreted LBP and TGF-β and underwent PMT also upon TGF-β receptor-blocking, indicating the crucial pro-fibrotic role of TLR4 signaling. Our data demonstrate that the selective removal of LBP may represent a therapeutic option to prevent PMT and the development of acute renal fibrosis in sepsis-induced AKI.

1 January 2008 in Veterinary and Comparative Orthopaedics and Traumatology
Verified
Journal Article
Closed access
PDF file
Francesco Paolo FanizziFrancesco Paolo Fanizzi
Francesco Paolo Fanizzi
EFE. Francioso
E. Francioso
ACANTONIO CROVACE
ANTONIO CROVACE
LLLuca Lacitignola
Luca Lacitignola
Proton magnetic resonance spectroscopy (1H NMR) has been successfully used in the study of many biological fluids. The data presented here report on the metabolic profiles of normal equine synovial fluids compared with osteoarthritic (OA) fluids. Twenty-five OA synovial fluid samples and eight normal ones were collected from the forelimb fetlock joint in 22 horses, aged between five and 24 years. 1H NMR spectroscopy was carried out with a Bruker Avance DRX 500 equiped with a cryomagnet working at 11 Tesla, and ‘Mestre-C 4.9.9.6’ software was used to analyze the spectra. The study assessed the increase of lactate, alanine, acetate, N-acetylglucosamine, pyruvate, citrate, creatine/creatinine, glycerol, HDL choline, and α-glucose in OA synovial fluid. The variations observed in samples from horses with OA compared to those in the control group, and similar data found in other studies, confirm that this technique may be useful in the study of joint metabolism. Its practical application may be in the evaluation of the treatment of OA in athletic horses.